Omnicell’s OMCL increasing cost of production continues to hamper the company’s margin performance. Weak hospital spending trends and tough competition also pose threats. The stock currently has a ...
Automating the future of patient care. That's Omnicell's goal for its new Innovation Lab, which is opening in Austin next week. Michael Garel, senior director of innovation at Omnicell, told the ...
Omnicell's OMCL strategic acquisitions and partnerships support each of the three pillars of the company’s strategy. Yet, the increasing cost of production continues to hamper the company’s margin ...
Omnicell Inc. reported its fourth-quarter 2025 earnings, revealing a miss in earnings per share (EPS) expectations but slightly surpassing revenue forecasts. The company’s EPS came in at $0.40, below ...
As states continue to administer COVID-19 vaccines through retail pharmacies, many are turning to digital tools to help efficiently manage the rollout. Among the solutions being used in Omnicell's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results